A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

Sponsor
Hoffmann-La Roche (Industry)
Overall Status
Completed
CT.gov ID
NCT00002377
Collaborator
(none)
19
71

Study Details

Study Description

Brief Summary

To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the pharmacokinetics of ganciclovir following administration of RS-79070 in the target population.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Intervention Model:
Parallel Assignment
Primary Purpose:
Treatment
Actual Study Start Date :
Jan 1, 1997
Actual Primary Completion Date :
Dec 1, 2002
Actual Study Completion Date :
Dec 1, 2002

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    14 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Documented AIDS diagnosis

    • Newly diagnosed peripheral CMV retinitis

    • More than 3 weeks of previous therapy for CMV retinitis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Univ of California / Irvine Irvine California United States 92697
    2 Univ of California / San Diego / Dept of Pediatrics La Jolla California United States 92093
    3 Univ of California / San Diego Treatment Ctr San Diego California United States 92103
    4 Davies Med Ctr / Institute for HIV Research San Francisco California United States 94114
    5 Kaiser Permanente Med Ctr San Francisco California United States 94115
    6 QUEST Clinical Research San Francisco California United States 94115
    7 Dr Alan Palestine Washington, D.C. District of Columbia United States 20006
    8 Univ of Miami School of Medicine Miami Florida United States 33136
    9 Emory Eye Clinic Atlanta Georgia United States 30322
    10 New England Med Ctr Boston Massachusetts United States 02111
    11 New York Univ Med Ctr New York New York United States 10016
    12 St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis New York New York United States 10019
    13 New York Hosp - Cornell Med Ctr New York New York United States 10021
    14 Duke Univ Eye Ctr Durham North Carolina United States 27710
    15 Austin Infectious Disease Consultants Austin Texas United States 78705
    16 St Pauls Hosp Vancouver British Columbia Canada
    17 The Toronto Hosp / Dept of Infectious Disease Toronto Ontario Canada
    18 Montreal Chest Institute Montreal Quebec Canada
    19 Royal Victoria Hosp Montreal Quebec Canada

    Sponsors and Collaborators

    • Hoffmann-La Roche

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hoffmann-La Roche
    ClinicalTrials.gov Identifier:
    NCT00002377
    Other Study ID Numbers:
    • WV15376
    First Posted:
    Aug 31, 2001
    Last Update Posted:
    May 17, 2017
    Last Verified:
    Jul 1, 2005

    Study Results

    No Results Posted as of May 17, 2017